उत्पाद विवरण
Bortero 2 mg injection is a targeted anticancer therapy designed to combat multiple myeloma and mantle cell lymphoma, both of which are aggressive cancers affecting the bone marrow and immune system, respectively. This medication operates by inhibiting specific proteins within cancer cells, effectively disrupting their growth and promoting cell death. Patients receiving Bortero should be monitored for potential side effects, including low blood cell counts and an increased risk of infections, which are common concerns associated with cancer treatments. It is crucial to discuss any existing health conditions and medications with your healthcare provider prior to starting Bortero, as interactions may occur. Administered under the supervision of a qualified healthcare professional, this injection aims to enhance the quality of life for those battling these challenging malignancies. Always ensure you adhere to prescribed dosages and report any unusual symptoms to your doctor promptly. With its targeted approach, Bortero represents a significant advancement in the management of certain types of blood cancers, offering hope to patients in need of effective treatment options.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese